Physician profile
Deep U Parikh
NPI 1003235185
$14,346.49
in general payments reported to CMS, 2019-2025
13 companies · $730 in 2025
The $730 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $47.98 · 2021: $379 · 2022: $6,515 · 2023: $906 · 2024: $5,282 · 2025: $730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,240 · Food and Beverage: $2,187 · Honoraria: $1,390 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,240.00 |
| Food and Beverage | $2,187.32 |
| Honoraria | $1,390.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $7,640.00 | 2022-2024 | Clarus, Cirrus Hd-Oct, Forum |
| Alimera Sciences, INC. | $2,301.36 | 2021-2024 | Iluvien, Yutiq |
| Eyepoint US, INC. | $1,888.24 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $534.40 | 2023-2025 | Miebo, Xipere, Envista Mx60 Iol |
| Alcon Vision LLC | $394.62 | 2019-2024 | Clareon |
| Regeneron Healthcare Solutions, INC. | $362.20 | 2019-2025 | Eylea Hd |
| Allergan, INC. | $297.37 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $249.99 | 2023 | Acthar |
| Ani Pharmaceuticals, INC. | $161.77 | 2025 | Purified Cortrophin Gel, Yutiq |
| Glaukos Corporation | $160.83 | 2025 | Idosetr |
| Kala Pharmaceuticals, INC. | $125.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $123.83 | 2025 | Xdemvy |
| Regeneron Pharmaceuticals, INC. | $106.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deep Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.